Barbara N. I.
- Country
- Poland
- Department
- ETG Lublin
Research Overview
- Evaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- A Phase 3 Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis
Data & Insights
Has run more than one trial at 200 of 332 partner sites.
Specializations
Rheumatoid Arthritis Research
The investigator specializes in the treatment of moderate to severe rheumatoid arthritis, with particular focus on evaluating novel therapeutic approaches and biosimilar medications. Their research encompasses biologic disease-modifying antirheumatic drugs (DMARDs) and their clinical applications.
- Abatacept-based therapies
- Etanercept biosimilar studies
- Methotrexate combination therapy
Their work includes assessment of treatment efficacy through DAS28-CRP measurements and ACR20 response criteria.
Psoriatic Arthritis Studies
The investigator conducts research in psoriatic arthritis treatment, particularly focusing on axial disease manifestations and novel biological therapies. Their work includes evaluation of biologic-naive patients with active PsA.
- Guselkumab treatment evaluation
- Sonelokimab therapy assessment
- Axial disease management
Research focuses on measuring therapeutic responses through ACR50 criteria and axial symptom reduction.
Sjögren's Syndrome Investigation
The investigator leads studies in primary Sjögren's Syndrome, examining innovative therapeutic approaches for both general and systemic manifestations of the condition. Their research encompasses moderate to severe systemic disease activity.
- Deucravacitinib efficacy studies
- Dazodalibep evaluation
- Efgartigimod safety assessment
The research includes evaluation of treatment outcomes using ESSDAI improvement measures.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.